Product Information
GNP MUCUS DM MAX ER 1200-60 MG is a generic product labeled by AmerisourceBergen, priced at $0.5446 per EA under NDC 46122063774. Its NADAC has been published 282 times since May 12, 2021.
FDA first approved this application on Mar 5, 2018.
Strength
60; 1200 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122063774
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA207602FDA Approved
3/5/2018
On Market Since
1/8/2020
Pharmacological Classes
Price Statistics
The NADAC for GNP MUCUS DM MAX ER 1200-60 MG has been published 282 times since May 12, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5446 per EA |
|---|---|
| All-time high | $0.5653 (Jan 10, 2024) |
| All-time low | $0.4830 (Aug 18, 2021) |
| 52-week high | $0.5493 |
| 52-week low | $0.5233 |
| Median price | $0.5428 |
| Average price | $0.5362 |
| Largest weekly change | +11.7% (Oct 18, 2023) |
| Weeks tracked | 282 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan HBr, guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP MUCUS DM MAX ER 1200-60 MG?
The current National Average Drug Acquisition Cost (NADAC) for GNP MUCUS DM MAX ER 1200-60 MG, manufactured by AmerisourceBergen, is $0.5446 per EA (NDC 46122063774), effective Sep 30, 2026.
How has the price of GNP MUCUS DM MAX ER 1200-60 MG changed over time?
Over the history we have for it, the NADAC for GNP MUCUS DM MAX ER 1200-60 MG has held within roughly two percent of its current level. It has been tracked across 282 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for GNP MUCUS DM MAX ER 1200-60 MG?
Since May 12, 2021, the NADAC for GNP MUCUS DM MAX ER 1200-60 MG has ranged from a low of $0.4830 (Aug 18, 2021) to a high of $0.5653 (Jan 10, 2024), with a median of $0.5428 per EA.
Are there cheaper alternatives to GNP MUCUS DM MAX ER 1200-60 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP MUCUS DM MAX ER 1200-60 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP MUCUS DM MAX ER 1200-60 MG?
GNP MUCUS DM MAX ER 1200-60 MG (NDC 46122063774) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.